Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial
Open Access
- 1 March 2013
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 381 (9868) , 744-751
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Council (G9721265)
This publication has 26 references indexed in Scilit:
- Have We Changed the Outcome in Membranous Nephropathy? A Propensity Study on the Role of Immunosuppressive TherapyClinical Journal of the American Society of Nephrology, 2011
- Rituximab Therapy in Idiopathic Membranous NephropathyClinical Journal of the American Society of Nephrology, 2010
- Inclusion of Rituximab in Treatment Protocols for Non-Hodgkin's Lymphomas and Risk for Progressive Multifocal LeukoencephalopathyThe Oncologist, 2010
- Low-Dose Cyclosporine Treatment in Chinese Nephrotic Patients With Idiopathic Membranous Nephropathy: An Uncontrolled Study With Prospective Follow-upThe American Journal of the Medical Sciences, 2010
- Membranous nephropathy: recent travels and new roads aheadKidney International, 2010
- Alkylating agents in membranous nephropathy: efficacy proven beyond doubtNephrology Dialysis Transplantation, 2010
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyNew England Journal of Medicine, 2009
- Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndromeNephrology Dialysis Transplantation, 2006
- A Randomized Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous NephropathyNew England Journal of Medicine, 1989
- Idiopathic membranous nephropathy: The natural history of untreated patientsKidney International, 1988